Shape Memory Medical Inc., developer of proprietary shape memory polymer technology for endovascular embolization, today announced the closing of a $10 million convertible note financing led by new ...
New funds will enable patient follow-up and data collection in the AAA-SHAPE trial and further progress in the FLAGSHIP study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results